14q32 translocations and 13q14 deletions are common cytogenetic abnormalities in POEMS syndrome

European Journal of Haematology

Volumn 91, Issue 6, 2013, Pages 490-496

  Kang, Wen Ying ^a   Shen, Kai Ni ^a   Duan, Ming Hui ^a   Zhang, Wei ^a   Cao, Xin Xin ^a   Zhou, Dao Bin ^a   Li, Jian ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

Cytogenetic abnormalities; Fluorescence in situ hybridization; POEMS syndrome

Indexed keywords

M PROTEIN; SYNDECAN 1; VASCULOTROPIN;

ADULT; AGED; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ARTICLE; BONE MARROW CELL; CHROMOSOME 13Q; CHROMOSOME 14Q; CHROMOSOME 17; CHROMOSOME 1Q; CLINICAL ARTICLE; CLINICAL FEATURE; CYTOGENETICS; FEMALE; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; GENE REARRANGEMENT; GENETIC ASSOCIATION; GENETIC TRAIT; HUMAN; INTERPHASE; KARYOTYPE; MALE; MULTIPLE MYELOMA; NUMERICAL CHROMOSOME ABERRATION; PAPILLEDEMA; PLASMA CELL; PLASMACYTOMA; POEMS SYNDROME; POLYNEUROPATHY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TUMOR VOLUME;

CYTOGENETIC ABNORMALITIES; FLUORESCENCE IN SITU HYBRIDIZATION; POEMS SYNDROME;

ADULT; AGED; BONE MARROW; CHROMOSOME ABERRATIONS; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 13; CHROMOSOMES, HUMAN, PAIR 14; FEMALE; GENE REARRANGEMENT; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; POEMS SYNDROME; TRANSLOCATION, GENETIC;

EID: 84888059646     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/ejh.12189     Document Type: Article

References (15)

1. Li J, Zhou DB. New advances in the diagnosis and treatment of POEMS syndrome. Br J Haematol 2013;161:303-15.
2. Kumar S, Fonseca R, Ketterling RP, et al. Trisomies in multiple myeloma: impact on survival in patients with high-risk cytogenetics. Blood 2012;119:2100-5.
3. Bochtler T, Hegenbart U, Cremer FW, et al. Evaluation of the cytogenetic aberration pattern in amyloid light chain amyloidosis as compared with monoclonal gammopathy of undetermined significance reveals common pathways of karyotypic instability. Blood 2008;111:4700-5.
4. Bacher U, Haferlach T, Kern W, Alpermann T, Schnittger S, Haferlach C. Correlation of cytomorphology, immunophenotyping, and interphase fluorescence in situ hybridization in 381 patients with monoclonal gammopathy of undetermined significance and 301 patients with plasma cell myeloma. Cancer Genet Cytogenet 2010;203:169-75.
5. Rose C, Zandecki M, Copin MC, Gosset P, Labalette M, Hatron PY, Jauberteau MO, Devulder B, Bauters F, Facon T. POEMS syndrome: report on six patients with unusual clinical signs, elevated levels of cytokines, macrophage involvement and chromosomal aberrations of bone marrow plasma cells. Leukemia 1997;11:1318-23.
6. Bryce AH, Ketterling RP, Gertz MA, et al. A novel report of clg-FISH and cytogenetics in POEMS syndrome. Am J Hematol 2008;83:840-1.
7. Dispenzieri A. POEMS syndrome. Blood Rev 2007;21:285-99.
8. Graham RC, Hughes RAC. A modified peripheral neuropathy scale: the Overall Neuropathy Limitations Scale. J Neurol Neurosurg Psychiatry 2006;77:973-6.
9. Hashiguchi T, Arimura K, Matsumuro K, Otsuka R, Watanabe O, Jonosono M, Maruyama Y, Maruyama I, Osame M. Highly concentrated vascular endothelial growth factor in platelets in Crow-Fukase syndrome. Muscle Nerve 2000;23:1051-6.
10. Ross FM, Avet-Loiseau H, Ameye G, et al. Report from the European Myeloma Network on interphase FISH in multiple myeloma and related disorders. Haematologica 2012;97:1272-7.
11. Dispenzieri A. POEMS syndrome: 2011 update on diagnosis, risk-stratification, and management. Am J Hematol 2011;86:592-601.
12. Sawyer JR. The prognostic significance of cytogenetics and molecular profiling in multiple myeloma. Cancer Genet 2011;204:3-12.
13. Xiong W, Wu XS, Starnes S, Johnson SK, Haessler J, Wang SQ, Chen LJ, Barlogie B, Shaughnessy JD, Zhan FH. An analysis of the clinical and biologic significance of TP53 loss and the identification of potential novel transcriptional targets of TP53 in multiple myeloma. Blood 2008;112:4235-46.
14. Bochtler T, Hegenbart U, Heiss C, et al. Hyperdiploidy is less frequent in AL amyloidosis compared with monoclonal gammopathy of undetermined significance and inversely associated with translocation t(11;14). Blood 2011;117:3809-15.
15. Bryce AH, Ketterling RP, Gertz MA, et al. Translocation t(11;14) and survival of patients with light chain (AL) amyloidosis. Haematologica 2009;94:380-6.